The result calculated by GME implied that by 2026, the Global Recombinant Proteins Market will grow with a CAGR of 9.1 percent. The growing high incidence of chronic diseases, and growing focus on customized medicine and protein therapeutics will enhance the market’s outlook in the forecast period.
Browse 155 Market Data Tables and 115 Figures
spread through 185 Pages and in-depth TOC on "Global Recombinant Proteins Market - Forecast to 2026."
https://www.globalmarketestimates.com/market-report/global-recombinant-proteins-market-2908
By
Product (Adhesion Molecules and Receptors, Growth Factors and Chemokines,
Membrane Proteins, Structural Proteins, Kinase Proteins, Recombinant Metabolic
Enzymes, Immune Response Proteins, Regulatory Proteins, Others), By Application
(Biotechnology Research, Drug Discovery & Development, Biopharmaceutical
Production, Academic Research Studies, Others), By End-User (Biotechnology
Companies, CROs, Pharmaceutical & Biopharmaceutical Companies, Academic
Research Institutes, Others), By Region (North America,
Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape,
Company Market Share Analysis & Competitor Analysis
Key Market Insights
· Recombinant proteins are formed from cloned DNA sequences that typically encode a known working enzyme or protein.
·
The growth
factors and chemokines accounted for the largest revenue share and are also projected to broaden at a high CAGR over the
projected timeframe owing to its use in numerous research fields such as neurobiology, cancer,
COVID-19, immunology, and HIV/AIDS, among others
·
The North American region remains the
leading marketplace in terms of sales, whereas a substantial CAGR rate will be exhibited by the
Asia-Pacific region over the projected timeframe.
·
Thermo Fisher Scientific Inc., Abcam
Plc, Biolegend, Bps Bioscience, Inc., Genscript Biotech Corporation, Peprotech,
Inc., Sino Biological Inc., Aviva Systems Biology Corporation, Icosagen As,
Prospec-Technogene Ltd., Raybiotech, Inc., Stemcell Technologies Inc., United
States Biological,Proteintech Group, Merck Kgaa, Abnova Corporation, Bio-Rad
Laboratories, Inc., Enzo Life Sciences, Inc., MiltenyiBiotec, Acrobiosystems,
CellgenixGmbh, Neuromics, Proteogenix, Richcore Lifesciences Pvt Ltd., and
Stressmarq Biosciences Inc., among
others are the prime competitors that compete in the market.
Browse the
Report @ https://www.globalmarketestimates.com/market-report/global-recombinant-proteins-market-2908
Product Outlook (Revenue, USD Billion,
2021-2026)
·
Adhesion
Molecules and Receptors
·
Growth Factors
and Chemokines
·
Membrane
Proteins
·
Structural
Proteins
·
Kinase
Proteins
·
Recombinant
Metabolic Enzymes
·
Immune
Response Proteins
·
Regulatory
Proteins
·
Others
Application Outlook (Revenue, USD Billion,
2021-2026)
·
Biotechnology Research
·
Drug Discovery & Development
·
Biologics
·
Vaccines
·
Cell & Gene Therapy
·
Biopharmaceutical Production
·
Academic Research Studies
·
Others
End-User Outlook (Revenue, USD Billion,
2021-2026)
·
Biotechnology Companies
·
CROs
·
Pharmaceutical & Biopharmaceutical Companies
·
Academic Research Institutes
·
Others
Regional Outlook
(Revenue, USD Billion, 2021-2026)
North America
- The
U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest
of Europe
Asia Pacific
- China
- India
- Japan
- South
Korea
- Australia
- Rest
of APAC
Central
& South America
- Brazil
- Argentina
- Rest
of CSA
Middle
East & Africa
- Saudi
Arabia
- UAE
- Rest
of MEA
Contact:
Tracy Simon
Email
address: tracy.simon@globalmarketestimates.com
Phone
Number: +16026667238
Website:
https://www.globalmarketestimates.com/
No comments:
Post a Comment